mebeverine has been researched along with Obesity in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Corrêa, CR; Ferron, AJT; Francisqueti-Ferron, FV; Garcia, JL; Gregolin, CS; Mattei, L; Minatel, IO; Moreto, F; Nakandakare-Maia, ET; Silva, CCVA; Silva, JDCP | 1 |
| Abe, K; Kaname, T; Kozuka, C; Masuzaki, H; Matsushita, M; Shimizu-Okabe, C; Takayama, C; Tsutsui, M | 1 |
| Fu, X; Liang, Y; Lin, Q; Luo, F; Luo, Y; Nie, Y; Shen, J; Tang, Y; Wang, L; Yang, T | 1 |
| Kozuka, C; Masuzaki, H; Okamoto, S; Shimabukuro, M; Tanaka, H; Yonamine, M | 1 |
| Eitsuka, T; Hashimoto, H; Ito, J; Kato, S; Kobayashi, E; Kokumai, T; Miyazawa, T; Nakagawa, K; Sawada, K; Shimizu, N | 1 |
| Guo, XX; Ji, BP; Qian, YZ; Qiu, J; Wang, K; Wang, Y; Zeng, Z; Zhou, F | 1 |
| Correa, CR; Fecchio, D; Han, SI; Lee, YM; Minatel, IO; Yeum, KJ; Yoon, H; Yoon, Y | 1 |
| Abe, K; Egashira, K; Fukuda, K; Kamei, A; Kinjo, A; Kondo, T; Kozuka, C; Masuzaki, H; Morinaga, H; Nakano, K; Shimizu-Okabe, C; Takayama, C; Yasuoka, A | 1 |
| Alvarez de Sotomayor, M; Claro, CM; Herrera, MD; Justo, ML; Parrado, J; Rodriguez-Rodriguez, R | 1 |
1 review(s) available for mebeverine and Obesity
| Article | Year |
|---|---|
Brown rice-specific γ-oryzanol as a promising prophylactic avenue to protect against diabetes mellitus and obesity in humans.
Topics: Animals; Diabetes Mellitus; Diet, High-Fat; Endoplasmic Reticulum Stress; Humans; Hypothalamus; Islets of Langerhans; Obesity; Oryza; Phenylpropionates; Reward | 2019 |
8 other study(ies) available for mebeverine and Obesity
| Article | Year |
|---|---|
Antioxidant and anti-inflammatory properties of gamma- oryzanol attenuates insulin resistance by increasing GLUT- 4 expression in skeletal muscle of obese animals.
Topics: Animal Nutritional Physiological Phenomena; Animals; Anti-Inflammatory Agents; Antioxidants; Blood Glucose; Fasting; Glucose Tolerance Test; Glucose Transporter Type 4; Inflammation; Insulin; Insulin Resistance; Lipid Peroxidation; Male; Muscle, Skeletal; Obesity; Phenylpropionates; Protein Carbonylation; Rats, Wistar | 2021 |
Impact of brown rice-specific γ-oryzanol on epigenetic modulation of dopamine D2 receptors in brain striatum in high-fat-diet-induced obesity in mice.
Topics: Animals; Brain; Diet, High-Fat; DNA Methylation; Feeding and Eating Disorders; Male; Mice; Mice, Inbred C57BL; Obesity; Oryza; Phenylpropionates; Receptors, Dopamine D2 | 2017 |
Oryzanol Modifies High Fat Diet-Induced Obesity, Liver Gene Expression Profile, and Inflammation Response in Mice.
Topics: Adipocytes; Adipose Tissue; Animals; Cholesterol; Diet, High-Fat; Humans; Hypolipidemic Agents; Liver; Male; Mice; Mice, Inbred ICR; NF-kappa B; Obesity; Phenylpropionates; Triglycerides | 2017 |
Evaluation of γ-oryzanol Accumulation and Lipid Metabolism in the Body of Mice Following Long-Term Administration of γ-oryzanol.
Topics: Adipose Tissue; Animals; Diet; Diet, High-Fat; Disease Models, Animal; Female; Fetal Development; Hypolipidemic Agents; Lipid Metabolism; Lipids; Liver; Male; Maternal-Fetal Exchange; Mice; Mice, Inbred C57BL; Obesity; Organ Size; Phenylpropionates; Pregnancy; Rats; Rats, Sprague-Dawley; Soybean Oil; Tissue Distribution | 2019 |
Wheat Flour, Enriched with γ-Oryzanol, Phytosterol, and Ferulic Acid, Alleviates Lipid and Glucose Metabolism in High-Fat-Fructose-Fed Rats.
Topics: Animal Feed; Animals; Biomarkers; Blood Glucose; Coumaric Acids; Dietary Sugars; Disease Models, Animal; Flour; Food, Fortified; Fructose; Hep G2 Cells; Humans; Lipids; Male; Metabolic Diseases; Obesity; Phenylpropionates; Phytosterols; Rats, Sprague-Dawley; Signal Transduction; Triticum | 2019 |
Antiadipogenic Activity of γ-Oryzanol and Its Stability in Pigmented Rice.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Adipose Tissue; Animals; Cell Line; Drug Stability; Food Handling; Food Preservation; Hot Temperature; Humans; Mesenchymal Stem Cells; Mice; Obesity; Oryza; Phenylpropionates; Pigments, Biological; Seeds; Temperature | 2016 |
Marked augmentation of PLGA nanoparticle-induced metabolically beneficial impact of γ-oryzanol on fuel dyshomeostasis in genetically obese-diabetic ob/ob mice.
Topics: Administration, Oral; Animals; Behavior, Animal; Blood Glucose; Diabetes Mellitus; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Carriers; Drug Compounding; Endoplasmic Reticulum Stress; Energy Metabolism; Food Preferences; Gastrointestinal Microbiome; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Intestinal Absorption; Islets of Langerhans; Lactic Acid; Lipids; Liver; Male; Mice, Obese; Nanomedicine; Nanoparticles; Obesity; Phenylpropionates; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Technology, Pharmaceutical; Time Factors | 2017 |
Water-soluble rice bran enzymatic extract attenuates dyslipidemia, hypertension and insulin resistance in obese Zucker rats.
Topics: Adiponectin; Animals; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Diet; Dyslipidemias; Fatty Acids, Nonesterified; Hypertension; Insulin; Insulin Resistance; Metabolic Syndrome; Nitrates; Obesity; Oryza; Phenylpropionates; Phytosterols; Plant Extracts; Rats; Rats, Zucker; Triglycerides; Water | 2013 |